Sequence: YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3
Molecular Formula: C223H343F3N46O70
Molecular Weight: 4845.44 g/mol
PubChem SID: 474492335
CAS Number: 2381089-83-2
Synonyms: LY-3437943, NOP2Y096GV
Store in a cool, dry place away from light.If Constituted, Please RefrigerateFor long-term storage, freezing at -20°C is recommended to maintain integrity.
| Description | Retatrutide is a promising new treatment option for individuals with type 2 diabetes and obesity. As a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, Retatrutide mimics the natural hormone GLP-1, which plays a crucial role in regulating blood sugar levels and promoting satiety. By stimulating the release of insulin and reducing glucagon production, Retatrutide helps to improve blood sugar control. Additionally, its ability to increase feelings of fullness and reduce appetite can aid in weight loss or weight maintenance. Studies have also demonstrated that Retatrutide can reduce the risk of heart attack and stroke in people with type 2 diabetes. Retatrutide offers the convenience of once-weekly injections, making it a practical treatment option for patients. Currently undergoing clinical trials, Retatrutide has shown promising results in terms of safety and efficacy. If approved, it could provide a valuable new tool for managing type 2 diabetes and obesity. |
| Sequence | H-Y-Aib-QGTFTSDYSI-MeL-LDK-K(AEEA-gamma Glu-C20 Diacid )-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH2 |
| Sequence (3 Letter) | H-Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-(α-Me-Leu)-Leu-Asp-Lys- Lys(AEEA-gamma Glu-C20 Diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Molecular Weight | 4731.33 |
| Properties | |
|---|---|
| Purity | > 99% By HPLC |
| Storage | Store at -20 °C, Cap vial tightly at all times. |
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.
ProFit Peptides is a chemical supplier. ProFit Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ProFit Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products we offer are not intended to diagnose, treat, cure or prevent any disease.
Human/Animal Consumption Prohibited. Laboratory/In-Vitro Experimental Use Only
